Literature DB >> 15284434

Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: prospective multicenter study.

Thomas H Bryant1, Martin J Blomley, Thomas Albrecht, Paul S Sidhu, Edward L S Leen, Raffaella Basilico, James M Pilcher, Lucy H Bushby, Christian W Hoffmann, Christopher J Harvey, Madeleine Lynch, John MacQuarrie, Dennis Paul, David O Cosgrove.   

Abstract

PURPOSE: To evaluate in a prospective multicenter study whether conventional ultrasonographic (US) characterization of liver lesions can be improved by imaging during the liver-specific phase of SH U 508A uptake in the microbubble-specific agent detection imaging mode.
MATERIALS AND METHODS: One hundred forty-two patients with liver lesions underwent conventional gray-scale and color Doppler US and SH U 508A-enhanced US. Two radiologists blindly read digital cine clips and assigned scores for confidence in diagnosis of benignancy or malignancy, diagnosis of specific lesion types, and relative difference in SH U 508A uptake between the lesion and the liver parenchyma (ie, subjective conspicuity score [SCS]). Comparisons were made to see whether the addition of agent detection imaging led to improved diagnostic performance.
RESULTS: Receiver operating characteristic analysis revealed improved discrimination of benign and malignant lesions for readers 1 (P =.049) and 2 (P <.001). The number of patients with a correct diagnosis of benignancy or malignancy assigned by readers 1 and 2, respectively, improved from 114 and 113 to 125 and 128 with agent detection imaging (reader 1: P =.027; reader 2: P =.008; McNemar test). Specific diagnoses were made more accurately with agent detection imaging: At McNemar testing, the number of correct lesion type determinations increased from 83 to 92 (P =.022) for reader 1 and from 85 to 99 (P <.001) for reader 2. Both readers assigned high scores for differences in SH U 508A uptake between the liver parenchyma and the lesion for metastases and cholangiocarcinomas and low scores for uptake differences in most of the benign lesions. Hepatocellular carcinomas (HCCs), hemangiomas, and adenomas had more variable uptake differences. Fourteen of 22 hemangiomas were assigned an SCS of less than 50%, and 22 (reader 1) and 15 (reader 2) of 31 HCCs were assigned an SCS of greater than 50%.
CONCLUSION: With use of SH U 508A-enhanced agent detection imaging, liver lesion characterization and diagnostic performance are significantly improved. Copyright RSNA, 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15284434     DOI: 10.1148/radiol.2323030596

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  21 in total

1.  Detection of focal liver lesions in cirrhotic liver using contrast-enhanced ultrasound.

Authors:  Grace Lai-Hung Wong; Hui-Xiong Xu; Xiao-Yan Xie
Journal:  World J Radiol       Date:  2009-12-31

2.  Malignant focal liver lesions at contrast-enhanced ultrasonography and magnetic resonance with hepatospecific contrast agent.

Authors:  M D'Onofrio; S Crosara; R De Robertis; S Canestrini; V Cantisani; G Morana; R Pozzi Mucelli
Journal:  Ultrasound       Date:  2013-12-13

3.  [Pitfalls in contrast-enhanced liver sonography: consequences for the practice].

Authors:  H Strunk; N Börner; G Stuckmann; D Hadizadeh
Journal:  Radiologe       Date:  2005-06       Impact factor: 0.635

Review 4.  Recent applications of ultrasound: diagnosis and treatment of hepatocellular carcinoma.

Authors:  Hitoshi Maruyama; Masaaki Ebara
Journal:  Int J Clin Oncol       Date:  2006-08       Impact factor: 3.402

Review 5.  Microbubble ultrasound contrast agents: an update.

Authors:  Emilio Quaia
Journal:  Eur Radiol       Date:  2007-03-10       Impact factor: 5.315

6.  Contrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases.

Authors:  H Maruyama; M Takahashi; H Ishibashi; M Yoshikawa; O Yokosuka
Journal:  Br J Radiol       Date:  2011-01-11       Impact factor: 3.039

7.  How often hepatocellular carcinoma has a typical pattern in contrast enhanced ultrasound?

Authors:  Alina Martie; Ioan Sporea; Roxana Sirli; Alina Popescu; Mirela Danila
Journal:  Maedica (Buchar)       Date:  2012-09

8.  Contrast-enhanced ultrasonographic findings of hepatic paragonimiasis.

Authors:  Qiang Lu; Wen-Wu Ling; Lin Ma; Zi-Xing Huang; Chang-Li Lu; Yan Luo
Journal:  World J Gastroenterol       Date:  2013-04-07       Impact factor: 5.742

Review 9.  Echographic imaging of tumoral cells through novel nanosystems for image diagnosis.

Authors:  Marco Di Paola; Fernanda Chiriacò; Giulia Soloperto; Francesco Conversano; Sergio Casciaro
Journal:  World J Radiol       Date:  2014-07-28

Review 10.  Current role of ultrasound for the management of hepatocellular carcinoma.

Authors:  Hitoshi Maruyama; Masaharu Yoshikawa; Osamu Yokosuka
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.